Semaglutides and Obesity: The Revolution is Here
Unlocking Healthspan
•
58m
Semaglutides are storming the world: this class of drugs not only achieves a reduction in weight of 15 to 20%, but they also appear to protect the heart, liver, and kidneys. Want to know more?
Based on current research, Goldman Sachs estimates the Semaglutides market to reach $100bn by 2030. Join Chris Shibutani, Goldman Sachs Global Investment Research Senior Biotechnology Analyst, for an enlightening session as we explore the next generation GLP1 based anti-obesity/weight management medications. The effect on industries, from pharmaceutical to insurance, medical technologies, food sectors, and airlines, will be disruptive and unpredictable. YPOers will get to explore present facts and future trends with Chris and determine the efficacy of the drugs, the present and future players, and the potential effects on healthcare.
YPOers will leave this event with:
• An understanding of the present impact of these drugs.
• The science behind the drug’s effect on individuals.
• A preview of important innovations in the pipeline.
Up Next in Unlocking Healthspan
-
LAP S05 - Robin Farmanfarmaian: Healt...
Robin Farmanfarmaian highlights innovative strategies and tools redefining patient experiences and outcomes. Learn and explore:
- How home-based healthcare solutions, supported by private and Medicare initiatives, are democratizing access and improving patient outcomes.
- The role of advanced tec... -
Wellness Wednesday: The Surprising Tr...
If you’re a serious health enthusiast, you may know that too much uric acid can cause uncomfortable symptoms. But what if it also provided some astonishing benefits? Want to know more? Dr. David Perlmutter can take it from here.
Join us for this informative Wellness Wednesday with Dr. Perlmutte...
-
In the Vanguard of Early Cancer Detec...
Join us for a 30-minute virtual fireside chat with Dr. Josh Ofman from GRAIL, as we explore the future of cancer detection:
- Why Early Detection Matters: Learn why finding cancer early is crucial.
- Future of Surveillance: Discover how advanced technology is shaping proactive cancer surveillan...
